Biosimilar Equal to Natalizumab for Relapsing-Remitting MS ...Middle East

Medscape - News
A novel biosimilar matches natalizumab in terms of efficacy, safety, and immunogenicity in patients with relapsing remitting multiple sclerosis, results from a new phase 3 trial show. Medscape Medical News

Hence then, the article about biosimilar equal to natalizumab for relapsing remitting ms was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Biosimilar Equal to Natalizumab for Relapsing-Remitting MS )

Apple Storegoogle play

Last updated :

Also on site :